This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow P3Rs: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when P3Rs are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My File Cabinet
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Benitz, W. E.
Right arrow Articles by Ramachandra, P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benitz, W. E.
Right arrow Articles by Ramachandra, P.
Related Collections
Right arrow Infectious Disease & Immunity

PEDIATRICS Vol. 102 No. 4 October 1998, p. e41

ELECTRONIC ARTICLE:
Serial Serum C-Reactive Protein Levels in the Diagnosis of Neonatal Infection

Received Sep 11, 1997; accepted Apr 29, 1998.

William E. Benitz, Michael Y. Han, Ashima Madan, and Pramela Ramachandra

From the Division of Neonatal and Developmental Medicine, Department of Pediatrics, Stanford University School of Medicine, Stanford, California.

Objective.  To evaluate serial serum C-reactive protein (CRP) levels for diagnosis of neonatal infection.

Setting.  A regional intensive care nursery and two community intensive care nurseries.

Methods.  All neonates treated for suspected bacterial infection were prospectively evaluated using a standardized clinical pathway. Infants were categorized as having proven sepsis (bacteria isolated from blood, cerebrospinal fluid, or urine culture), probable sepsis (clinical and laboratory findings consistent with bacterial infection without a positive culture), or no sepsis (findings not consistent with sepsis), without consideration of CRP levels. Infants whose blood cultures yielded skin flora but who demonstrated no other signs of bacterial infection were not considered to have sepsis. CRP levels were determined at the initial evaluation and on each of the next two mornings. Sensitivity, specificity, predictive values, and likelihood ratios were calculated for the first (CRP #1), second (CRP #2), higher of the second and third (CRP #2 and #3), or highest of all three CRP levels (CRP × 3).

Results.  Sepsis was suspected within the first 3 days after birth in 1002 infants (early-onset) and on 184 occasions in 134 older infants (late-onset). There were 20 early-onset and 53 late-onset episodes of proven sepsis, and 74 early-onset and 12 late-onset episodes of probable sepsis. CRP #1 had sensitivities of 39.4% and 64.6% for proven or probable sepsis and 35.0% and 61.5% for proven sepsis in early-onset and late-onset episodes, respectively. CRP levels on the morning after the initial evaluation (CRP #2) had higher sensitivities (92.9% and 85.0% for proven or probable sepsis and 78.9% and 84.4% for proven sepsis in early-onset and late-onset episodes, respectively), and normal results were associated with lower likelihoods of infection (likelihood ratios for normal results of 0.10 and 0.19 for proven or probable sepsis and 0.27 and 0.21 for proven sepsis, in early-onset and late-onset episodes, respectively). Three serial serum CRP levels had sensitivities of 97.8% and 98.1% for proven or probable sepsis and 88.9% and 97.5% for proven sepsis in early-onset and late-onset episodes, respectively. The negative predictive values for CRP × 3 were 99.7% and 98.7% for both proven or probable sepsis and for proven sepsis in early-onset and late-onset episodes, respectively. A CRP level obtained at the time of the initial evaluation can be omitted without significant loss of sensitivity or negative predictive value: the sensitivities of CRP #2 and #3 were 97.6% and 94.4% for proven or probable sepsis and 88.9% and 96.4% for proven sepsis in early-onset and late-onset episodes, respectively; negative predictive values were 99.7% both for proven and for proven or probable early-onset sepsis, 97.6% for proven or probable late-onset infection, and 98.8% for proven late-onset infection. Serial normal CRP levels were associated with a markedly reduced likelihood of infection as compared with that in the entire population before testing, with likelihood ratios ranging from 0.03 to 0.16 for the various subgroups. Maximum CRP levels >3 mg/dL had positive predictive values >20% for proven or probable early-onset infections and for proven or probable and proven late-onset infections, but only those >6 mg/dL had such a high positive predictive value for proven early-onset sepsis.

Conclusions.  Serial CRP levels are useful in the diagnostic evaluation of neonates with suspected infection. Two CRP levels <1 mg/dL obtained 24 hours apart, 8 to 48 hours after presentation, indicate that bacterial infection is unlikely. The sensitivity of a normal CRP at the initial evaluation is not sufficient to justify withholding antibiotic therapy. The positive predictive value of elevated CRP levels is low, especially for culture-proven early-onset infections.  Key words:  bacterial infection, C-reactive protein, human, infant-newborn, sensitivity and specificity, acute-phase proteins, neonatal sepsis.




This article has been cited by other articles:


Home page
 NeoReviewsHome page
J.-H. Weitkamp and J. L. Aschner
Diagnostic Use of C-Reactive Protein (CRP) in Assessment of Neonatal Sepsis
NeoReviews, November 1, 2005; 6(11): e508 - e515.
[Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
D Behrendt, J Dembinski, A Heep, and P Bartmann
Lipopolysaccharide binding protein in preterm infants
Arch. Dis. Child. Fetal Neonatal Ed., November 1, 2004; 89(6): F551 - F554.
[Abstract] [Full Text] [PDF]

Home page
 Arch. Dis. Child. Fetal Neonatal Ed.Home page
M A Turner, S Power, and A J B Emmerson
Gestational age and the C reactive protein response
Arch. Dis. Child. Fetal Neonatal Ed., May 1, 2004; 89(3): F272 - F273.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
C. Chiesa, A. Panero, J. F. Osborn, A. F. Simonetti, and L. Pacifico
Diagnosis of Neonatal Sepsis: A Clinical and Laboratory Challenge
Clin. Chem., February 1, 2004; 50(2): 279 - 287.
[Full Text] [PDF]

Home page
 NeoReviewsHome page
P. F. Tumbaga and A. G. S. Philip
Perinatal Group B Streptococcal Infections: Past, Present, and Future
NeoReviews, March 1, 2003; 4(3): e65 - 72.
[Full Text] [PDF]

Home page
 Clin. Chem.Home page
C. Chiesa, G. Pellegrini, A. Panero, J. F. Osborn, F. Signore, M. Assumma, and L. Pacifico
C-Reactive Protein, Interleukin-6, and Procalcitonin in the Immediate Postnatal Period: Influence of Illness Severity, Risk Status, Antenatal and Perinatal Complications, and Infection
Clin. Chem., January 1, 2003; 49(1): 60 - 68.
[Abstract] [Full Text] [PDF]

Home page
 Clin. Chem.Home page
C. Chiesa, F. Signore, M. Assumma, E. Buffone, P. Tramontozzi, J. F. Osborn, and L. Pacifico
Serial Measurements of C-Reactive Protein and Interleukin-6 in the Immediate Postnatal Period: Reference Intervals and Analysis of Maternal and Perinatal Confounders
Clin. Chem., June 1, 2001; 47(6): 1016 - 1022.
[Abstract] [Full Text] [PDF]

Home page
 CLIN PEDIATRHome page
J. Turow and A. R. Spitzer
Group B Streptococcal Infection Early Onset Disease Controversies in Prevention Guidelines, and Management Strategies for the Neonate
Clinical Pediatrics, June 1, 2000; 39(6): 317 - 326.
[Abstract] [PDF]